Skip to main content
. 2019 Jun 18;12:883–899. doi: 10.2147/DMSO.S207087

Table 1.

Patient characteristics (total study population, n=764)

Characteristic
Age (years) (n=763) 65.9±10.7
Age groups (n=763)
30–39 7 (0.9)
40–41 49 (6.4)
50–59 145 (19.0)
60–69 262 (34.3)
≥70 300 (39.3)
Sex (n=763)
Male 426 (55.8)
Female 337 (44.2)
Ethnicity (n=518)
Western-European 400 (77.2)
Dutch 396 (76.4)
Other 4 (0.8)
Other 118 (22.8)
Surinamese 59 (11.4)
Indonesian 18 (3.5)
Moroccan 14 (2.7)
Other 27 (5.2)
Education (n=518)
Primary 50 (9.7)
Secondary 196 (37.8)
Higher 272 (52.5)
Smoking (n=707)
Yes 112 (15.8)
No 595 (84.2)
Metabolic control (HbA1c) (n=715)
Good (≤53 mmol/mol) 479 (67.0)
Moderate (54–63 mmol/mol) 161 (22.5)
Poor (≥64 mmol/mol) 75 (10.5)
Obesity (BMI ≥30 kg/m2) (n=729)
Yes 287 (39.4)
No 444 (60.7)
Hypertension (SBP ≥140 mmHg) (n=729)
Yes 269 (36.9)
No 460 (63.1)
Dyslipidemia (LDL >2.5 mmol/L) (n=690)
Yes 300 (43.5)
No 390 (56.5)
Kidney dysfunction (eGFR <60 mL/min/1.73m2) (n=682)
Yes 142 (20.8)
No 540 (79.2)
Retinopathy (n=450)
Yes 18 (4.0)
No 432 (96.0)
Diabetic foot risk (n=639)
None (Simm’s 0) 457 (71.5)
Moderate (Simm’s 1) 90 (14.1)
High (Simm’s 2) 80 (12.5)
Very high (Simm’s 3) 12 (1.9)

Notes: For each parameter, the number of subjects with available data is provided. Data are presented as mean±SD or n (%). Note: When the n for a variable differs from the overall patient population, this is the result of missing data. Percentages represent only non-missing data.

Abbreviations: SPB, systolic blood pressure; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate.